Whitefort Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2M | Buy |
13,343,228
+35,261
| +0.3% | +$109K | 12.1% | 3 |
|
|
2025
Q1 | $46.4M | Buy |
13,307,967
+66,051
| +0.5% | +$231K | 21.85% | 1 |
|
|
2024
Q4 | $43.3M | Buy |
13,241,916
+373,949
| +3% | +$1.22M | 20.72% | 1 |
|
|
2024
Q3 | $49.5M | Hold |
12,867,967
| – | – | 22.56% | 1 |
|
|
2024
Q2 | $39.8M | Buy |
12,867,967
+5,815
| +0% | +$18K | 24.51% | 1 |
|
|
2024
Q1 | $33.2M | Sell |
12,862,152
-334,910
| -3% | -$864K | 20.21% | 2 |
|
|
2023
Q4 | $33M | Buy |
13,197,062
+1,301,585
| +11% | +$3.25M | 21.03% | 2 |
|
|
2023
Q3 | $24.1M | Buy |
11,895,477
+3,801,556
| +47% | +$7.72M | 12.66% | 3 |
|
|
2023
Q2 | $18.6M | Buy |
8,093,921
+593,895
| +8% | +$1.37M | 17.48% | 2 |
|
|
2023
Q1 | $22.7M | Buy |
7,500,026
+3,649,257
| +95% | +$11.1M | 21.12% | 2 |
|
|
2022
Q4 | $8.97M | Buy |
+3,850,769
| New | +$8.97M | 6.97% | 6 |
|